Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jose María Lopez‐Picazo"'
Autor:
Juan Pablo Fusco, Guillermo Pita, María José Pajares, Maria Pilar Andueza, Ana Patiño‐García, Juan P. de‐Torres, Alfonso Gurpide, Javier Zulueta, Rosario Alonso, Nuria Alvarez, Ruben Pio, Ignacio Melero, Miguel F. Sanmamed, Maria Rodriguez Ruiz, Ignacio Gil‐Bazo, Jose María Lopez‐Picazo, Ciro Casanova, Rebeca Baz Davila, Antonio Agudo, Maria Dolores Lozano, Alvaro Gonzalez, Nuria Sala, Eva Ardanaz, Javier Benitez, Luis Montuenga, Anna Gonzalez‐Neira, Jose Luis Perez‐Gracia
Publikováno v:
Cancer Medicine, Vol 7, Iss 7, Pp 3474-3483 (2018)
Abstract Single nucleotide polymorphisms (SNPs) may modulate individual susceptibility to carcinogens. We designed a genome‐wide association study to characterize individuals presenting extreme phenotypes of high and low risk to develop tobacco‐i
Externí odkaz:
https://doaj.org/article/c3b285810a764be5ae798d81e210d99b
Autor:
Rocío Figueroa, Ana Alfonso, María Marcos, José María López-Picazo, Alberto García-Mouriz, Ignacio Gil-Bazo, José Rifón, José Hermida, José Antonio Páramo, Ramón Lecumberri
Publikováno v:
TH Open, Vol 03, Iss 02, Pp e153-e156 (2019)
Externí odkaz:
https://doaj.org/article/ec7d2ce31c4e401fa94c58550479e403
Autor:
Celia Prior, Jose Luis Perez-Gracia, Jesus Garcia-Donas, Cristina Rodriguez-Antona, Elizabeth Guruceaga, Emilio Esteban, Cristina Suarez, Daniel Castellano, Aránzazu González del Alba, Maria Dolores Lozano, Joan Carles, Miguel Angel Climent, Jose Angel Arranz, Enrique Gallardo, Javier Puente, Joaquim Bellmunt, Alfonso Gurpide, Jose Maria Lopez-Picazo, Alvaro Gonzalez Hernandez, Begoña Mellado, Esther Martínez, Fernando Moreno, Albert Font, Alfonso Calvo
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e86263 (2014)
To identify tissue microRNAs predictive of sunitinib activity in patients with metastatic renal-cell-carcinoma (MRCC) and to evaluate in vitro their mechanism of action in sunitinib resistance.We screened 673 microRNAs using TaqMan Low-density-Arrays
Externí odkaz:
https://doaj.org/article/93829b422d804bc7841b6e9812135dcd
Autor:
Belen Sadaba, Anabel del Barrio, Miguel Angel Campanero, Jose Ramon Azanza, Almudena Gomez-Guiu, Jose Maria Lopez-Picazo, Salvador Martin Algarra, Francisco Guillén Grimá, Maria Blanco Prieto, Jose Luis Perez-Gracia, Alfonso Gurpide
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89747 (2014)
Palonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never been studied, even though it co
Externí odkaz:
https://doaj.org/article/732bd83ce7fe475ebabe0fd50f2fd1e3
Autor:
Iago Rodríguez-Lago, Susana de-la-Riva, José Carlos Subtil, María Dolores Lozano, José María López-Picazo, Miguel Muñoz-Navas
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 107, Iss 2, Pp 121-122 (2015)
Externí odkaz:
https://doaj.org/article/815a372822ba4b4198cfdfc6aa7cd262